MALARIA (PLASMODIUM FALCIPARUM)
Clinical trials for MALARIA (PLASMODIUM FALCIPARUM) explained in plain language.
Never miss a new study
Get alerted when new MALARIA (PLASMODIUM FALCIPARUM) trials appear
Sign up with your email to follow new studies for MALARIA (PLASMODIUM FALCIPARUM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising malaria vaccine enters key trial in africa
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new malaria vaccine (PfSPZ-LARC2) in 180 healthy adults aged 18-50 in Burkina Faso. The vaccine uses weakened malaria parasites that grow in the liver but stop there, training the immune system without causing blood-stage infection. Participants receive one or …
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE2 • Sponsor: Sanaria Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:55 UTC
-
Smart wristbands could sniff out malaria before you feel sick
Diagnosis Not yet recruitingThis study tests whether wearable devices like wristbands or earphones can detect malaria infection early by tracking changes in temperature, heart rate, and other body signals. Thirty-two healthy adults will be exposed to the malaria parasite or a placebo in a controlled setting…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: Diagnosis
Last updated May 11, 2026 20:53 UTC
-
New malaria shot could offer months of protection
Prevention Not yet recruitingThis early-stage study tests a single injection of MMV371, a long-acting medicine, to see if it safely prevents malaria in healthy adults and teens aged 12-50 in Rwanda. About 80 participants will get either the study drug or a placebo, and researchers will monitor them for 24 we…
Matched conditions: MALARIA (PLASMODIUM FALCIPARUM)
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Prevention
Last updated May 17, 2026 07:08 UTC